# Oxygen Plus, Inc. dba Summit Respiratory – FDA Inspection, Oct 14, 2010

Source: https://www.keypedia.com/records/fda_inspections/oxygen-plus-inc-dba-summit-respiratory/5f2ad61f-54f9-439e-8843-4ece35e760f9
Source feed: FDA_Inspections

> FDA inspection 685899 of Oxygen Plus, Inc. dba Summit Respiratory, October 14, 2010. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 685899
- Company Name: Oxygen Plus, Inc. dba Summit Respiratory
- Inspection Date: 2010-10-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

Company: https://www.keypedia.com/companies/oxygen-plus-inc-dba-summit-respiratory/01067235-ee09-4d04-a9f3-a55fa0db7940

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
